Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
CCR5 Extracellular Vesicles in Rheumatoid Arthritis
2026-09-14
A 2025 study identifies CCR5-bearing extracellular vesicles from rheumatoid arthritis synovial fibroblasts as active mediators of chondrocyte inflammation, cartilage destruction, and bone erosion. Using CCR5-deficient vesicles and vesicle-encapsulated Maraviroc in vitro and in an adjuvant-induced arthritis model, the work connects extracellular-vesicle trafficking with NF-κB-dependent joint pathology.
-
Prestained Protein Marker: Triple Color Ladder
2026-09-14
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible size references for SDS-PAGE, transfer monitoring, and Western blot protein size verification. It is appropriate for denaturing electrophoresis and compatible transfer or imaging workflows, but not for native protein analysis, direct protein quantification, or applications that require EDTA.
-
Gastric Cancer Assembloids with Matched Stroma
2026-09-13
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids by combining tumor organoids with stromal subpopulations isolated from the same tissue. Their findings show that matched stroma alters gene expression and drug sensitivity, providing a more physiologically informative platform for studying tumor–microenvironment interactions and personalized treatment responses.
-
SD 169: Selective p38 MAPK Inhibitor
2026-09-12
SD 169 is an indole-5-carboxamide and selective ATP-competitive inhibitor of p38α and p38β MAPKs. Product evidence supports its use in type 1 diabetes research, inflammatory signaling studies, and axonal regeneration research, while a separate preprint provides a structural framework for understanding inhibitor-linked p38α dephosphorylation.
-
BGJ398 (NVP-BGJ398): FGFR Research Guide
2026-09-11
BGJ398 (NVP-BGJ398) is a selective small-molecule inhibitor of FGFR1, FGFR2, and FGFR3, with nanomolar biochemical potency reported by the product dossier. It is a research tool for studying FGFR signaling, FGFR-dependent tumor biology, and apoptosis induction in cancer cells, but preclinical activity should not be interpreted as clinical efficacy.
-
Sodium-Driven Mitochondrial Failure in NECSO
2026-09-11
Qiao et al. define a mechanistic link between TRPM4-mediated sodium influx, mitochondrial ion imbalance, impaired energy metabolism, and necrosis by sodium overload (NECSO). The study places mitochondrial energy failure upstream of Na/K-ATPase collapse and identifies a framework for interpreting ion homeostasis, mitochondrial physiology, and necrotic cell death together.
-
Live-Dead Cell Staining Kit: K2081 Guide
2026-09-10
The Live-Dead Cell Staining Kit uses Calcein-AM Propidium Iodide staining to distinguish esterase-active, membrane-intact cells from membrane-compromised cells. Its two-color readout supports cell viability assay, flow cytometry, fluorescence microscopy, and drug cytotoxicity testing when appropriate controls are used.
-
Dasatinib Monohydrate: Assay Reliability Guide
2026-09-10
This scenario-based guide explains how Dasatinib Monohydrate (SKU B5954) can support more interpretable cell viability, proliferation, and cytotoxicity assays. It connects kinase potency, DMSO handling, dose selection, NET-related biology, and practical vendor evaluation to chronic myeloid leukemia research and resistance studies.
-
Bleomycin Sulfate: DNA Damage to Fibrosis
2026-09-09
Bleomycin Sulfate is more than a DNA strand break inducer: it can connect genotoxic injury with macrophage metabolism and fibrotic remodeling. This guide translates recent IGF2BP1–THBS1–TLR4 findings into practical assay design for oncology and pulmonary fibrosis research.
-
Senescent Microglia in Aged Brain White Matter
2026-09-09
The reference study combines spatial transcriptomics, molecular imaging, and intervention experiments to identify a senescence- and disease-associated microglial state concentrated in the fimbria of naturally aged mouse brain. Its findings suggest that GAL3-positive white-matter microglia are regionally organized and partially reversible, providing a framework for studying early white-matter dysfunction without equating molecular association with causation.
-
Arachidonic Acid in Ischemia-Reperfusion Assays
2026-09-08
Arachidonic Acid is a powerful mechanistic probe for studying lipid flux during cerebral ischemia-reperfusion. This article connects eicosanoid pathway analysis with a recent selective hypothermic perfusion study to improve assay design without overstating translational evidence.
-
Cyanine 5-dCTP: From Label to DNA Architecture
2026-09-08
Fluorescent DNA labeling is increasingly becoming a systems-engineering challenge rather than a simple reagent choice. This thought-leadership article connects Cyanine 5-dCTP with emerging DNA-framework strategies, showing how molecular incorporation, enzyme accessibility, assay controls, and translational decision-making can be integrated into a more reliable workflow.
-
JAK Inhibitors and Endothelial Cardiovascular Effects
2026-09-07
A 2025 comparative study tested six JAK inhibitors in cytokine-stimulated human endothelial cells and found a shared reduction in IL-6 but divergent effects on IL-8, adhesion molecules, coagulation markers, and apoptosis. Its side-by-side design shows why cardiovascular interpretation should consider inhibitor selectivity, concentration, and vascular endpoint rather than treating JAK inhibition as a uniform class effect.
-
PDGF-BB and the Metabolic Logic of Vascular Remodeling
2026-09-07
A translational framework for using murine recombinant PDGF-BB to distinguish receptor-driven mitogenesis from lactate-linked metabolic remodeling in pulmonary vascular research.
-
Asunaprevir (BMS-650032) HCV Assay Workflow
2026-09-05
Build a layered HCV research workflow around Asunaprevir (BMS-650032), moving from direct NS3/4A protease inhibition to cell-based HCV RNA replication inhibition. The article combines genotype-aware assay design, solvent and controls guidance, and a carefully bounded lesson from an orthogonal NUT carcinoma screening study.